Invention Grant
US06919331B2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
失效
取代的2-甲基 - 苯并咪唑呼吸道合胞病毒抗病毒剂
- Patent Title: Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
- Patent Title (中): 取代的2-甲基 - 苯并咪唑呼吸道合胞病毒抗病毒剂
-
Application No.: US10309505Application Date: 2002-12-04
-
Publication No.: US06919331B2Publication Date: 2005-07-19
- Inventor: Kuo-Long Yu , Xiangdong Wang , Yaxiong Sun , Christopher Cianci , Jan Willem Thuring , Keith Combrink , Nicholas Meanwell , Yi Zhang , Rita L. Civiello
- Applicant: Kuo-Long Yu , Xiangdong Wang , Yaxiong Sun , Christopher Cianci , Jan Willem Thuring , Keith Combrink , Nicholas Meanwell , Yi Zhang , Rita L. Civiello
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson; Samuel J. DuBoff
- Main IPC: C07D235/26
- IPC: C07D235/26 ; C07D401/06 ; C07D403/06 ; C07D413/14 ; C07D471/04 ; C07D513/04
Abstract:
The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
Public/Granted literature
- US20030207868A1 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents Public/Granted day:2003-11-06
Information query
